94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
An erratum on
Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers
By Fattahi MR, Dehghani M, Paknahad S, Rahiminia S, Zareie D, Hoseini B, Oroomi TR, Motedayyen H and Arefnezhad R (2024). Front. Oncol. 14:1438297. doi: 10.3389/fonc.2024.1438297
Due to a production error, there was an error in affiliation 1. Instead of “School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran”, it should be “Student Research Committee, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran”. The publisher apologizes for this mistake.
The original version of this article has been updated.
Keywords: nanomedicine, nanoparticle, urology, cancer, treatment, clinical, biosafety
Citation: Frontiers Production Office (2024) Erratum: Clinical insights into nanomedicine and biosafety: advanced therapeutic approaches for common urological cancers. Front. Oncol. 14:1516456. doi: 10.3389/fonc.2024.1516456
Received: 24 October 2024; Accepted: 24 October 2024;
Published: 05 November 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, Lausanne, SwitzerlandCopyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn